Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

Kaisa Health Group Holdings Limited

佳 兆 業 健 康 集 團 控 股 有 限 公 司

(Incorporated in Bermuda with limited liability)

(Stock Code: 876)

RESIGNATION OF CHIEF FINANCIAL OFFICER

The board (the "Board") of directors (the "Director(s)") of Kaisa Health Group Holdings Limited (the "Company") hereby announces that, Ms. Zhao Ai ("Ms. Zhao") ceased to be the chief financial officer of the Company (the "Chief Financial Officer") with effect from 14 October 2019.

Ms. Zhao has confirmed that she has no disagreement with the Board and there are no other matters relating to her resignation that need to be brought to the attention of the shareholders of the Company or The Stock Exchange of Hong Kong Limited.

The Board would like to express its gratitude to Ms. Zhao for her contributions to the Company during her term of service.

By order of the Board

Kaisa Health Group Holdings Limited

Kwok Ying Shing

Chairman

Hong Kong, 16 October 2019

As at the date of this announcement, the Board comprises four executive Directors, namely Mr. Kwok Ying Shing (Chairman), Mr. Luo Jun (Co-Vice Chairman), Mr. Wu Tianyu (Co-Vice Chairman) and Mr. Xu Hao, and four independent non-executive Directors, namely Dr. Liu Yanwen, Mr. Fok Hei Yu, Dr. Lyu Aiping and Mr. Lau Shui Fung.

Attachments

  • Original document
  • Permalink

Disclaimer

Mega Medical Technology Ltd. published this content on 16 October 2019 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 16 October 2019 09:32:08 UTC